1-3 of 3
Jean Paul Borg, PharmD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Cell Polarity PTK7 Receptor Is Expressed in Myeloid Cells and Acts as a Modulator of the Chemotherapeutic Response in AML Patients.

Thomas Prebet, MD, Anne Catherine Lhoumeau, PharmD, Christine Arnoulet, PharmD, Anais Aulas, Sylvie Marchetto, Michael Sebbagh, PhD, Benjamin Esterni, Norbert Vey, Jean Paul Borg, PharmD, PhD
Journal: Blood
Blood (2009) 114 (22): 1571.
https://doi.org/10.1182/blood.V114.22.1571.1571
Published: 2009
Journal Articles

Wide Range Sequencing of FLT3 Reveals a New Activating Mutation Associated with a Decreased Sensitivity to Tyrosine Kinase Inhibitors in Acute Myeloid Leukaemia.

Philippe Garrigue, Pharm, D, Thomas Prebet, MD, Sébastien Létard, PhD, Katia Hanssens, BSc, Wolfgang Sippl, PhD, Anne Lermet, PhD, Norbert Vey, Jean Paul Borg, PharmD, PhD, Patrice Dubreuil, PhD
Journal: Blood
Blood (2009) 114 (22): 3982.
https://doi.org/10.1182/blood.V114.22.3982.3982
Published: 2009
Journal Articles

Expression of the Cell Polarity Protein PTK7 in Acute Myeloid Leukaemia.

Thomas Prebet, MD, Anne Catherine Lhoumeau, PharmD, Christine Arnoulet, PharmD, Sylvie Marchetto, Christian Chabannon, MD, PhD, Danielle Sainty, MD, Norbert Vey, MD, Jean Paul Borg, PharmD, PhD
Journal: Blood
Blood (2008) 112 (11): 1478.
https://doi.org/10.1182/blood.V112.11.1478.1478
Published: 2008